Novonesis celebrates a milestone as Health Canada grants its probiotic strain, Clepius L. plantarum, official recognition for stress relief and gastro-functional benefits. Overcoming the rigorous approval process, Novonesis emphasizes the significance of these endorsements in guiding consumers towards informed health choices. The approved claims address common issues like perceived stress and irritable bowel syndrome (IBS), aligning with global concerns about digestive discomfort. By delving into the gut-brain axis, Novonesis acknowledges the profound impact of gut health on mental well-being. This recognition not only validates Clepius’s efficacy but also propels Novonesis into the forefront of the evolving biotics landscape, marked by innovations in synbiotics and personalized nutrition.
Home » Health Canada Grants Novonesis Probiotic Stress Relief and Gastro-Functional Claims Approval
Health Canada Grants Novonesis Probiotic Stress Relief and Gastro-Functional Claims Approval
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Hidden Gallbladder Risks with Popular GLP‑1 Drugs
July 24, 2026
Creatine Supports Brain Health During Menopause
July 24, 2026
Fiber: A Practical Complement to GLP‑1RA Therapy
July 19, 2026